SPON2 and metastatic malignant neoplasm in the lymph nodes: In addition, in order to evaluate the prognostic value of Spondin-2 in different subgroups, patients were stratified according to tumor size (Figure 4B, 4C), depth of invasion (Figure 4D, 4E), and lymph node metastasis (Figure 4F, 4G).